Please login or register first to view this content.
Oncology Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
- Bladder, kidney, and other urologic cancers
- Bone and connective tissue cancer
- Breast cancer
- CNS cancer
- Colorectal and other GI cancers
- Cytoprotective and supportive care agents
- Eye cancer
- Gynecologic cancer
- Head and neck cancer
- Kaposi’s sarcoma
- Leukemias, lymphomas, and other hematologic cancers
- Melanoma and other skin cancers
- Pancreatic, thyroid, and other endocrine cancers
- Prostate and other male cancers
- Respiratory and thoracic cancers
NEWS & FEATURES
Mirvetuximab Soravtansine Data Lacking for FDA’s Accelerated Approval in Ovarian CA
Chemotherapy-Free Combo Therapy Approved for Previously Untreated CLL
Bavencio Plus Inlyta Approved as First-Line Tx for Advanced Renal Cell Carcinoma
FDA Panel Backs Pexidartinib for Rare Tumor, Votes Against Quizartinib for FLT3-ITD AML
Cyramza Approved to Treat Hepatocellular Carcinoma
New Recommendations Developed for Breast Cancer Screening
Prostate Cancer Diagnosis Risk Lower in Users of Hydrophilic Statins
Oral Aspirin Does Not Up FIT Test Sensitivity for ID’ing CRC
Kadcyla Approved as Adjuvant Treatment for HER2-Positive Early Breast Cancer
AUA: Atenolol Linked to Drop in Low-, Intermediate-Risk Prostate Cancer
Tibsovo Approved to Treat Newly Diagnosed AML With IDH1 Mutation
Radical Hemithoracic Radiation Tx Ups Survival in Mesothelioma
Postchemo Radiation Tx May Benefit Some With Hodgkin Lymphoma
Targeted Therapy Promising for Rare Hematologic Cancer
Single-Dose Brachytherapy Effective for Prostate Cancer
Sucking Ice Chips Cuts Oral Side Effects of Oxaliplatin Chemo
Lartruvo Pulled From Market, Access Program to Be Established
Keytruda Combination Therapy Approved as First-Line Treatment of Advanced RCC
